key: cord-0867538-un2n0qig authors: Fan, Yihua; Liu, Wei; Jin, Yue; Hou, Xu; Zhang, Xuewu; Pan, Hudan; Lu, Hang; Guo, Xiaojing title: Integrated Molecular Docking with Network Pharmacology to Reveal the Molecular Mechanism of Simiao Powder in the Treatment of Acute Gouty Arthritis date: 2021-04-27 journal: Evid Based Complement Alternat Med DOI: 10.1155/2021/5570968 sha: 9917385ff67cdceaabe5517b9fb9a9884390c587 doc_id: 867538 cord_uid: un2n0qig BACKGROUND: The incidence of gout has been rapidly increasing in recent years with the changing of diet. At present, modern medications used in the clinical treatment of gout showed several side effects, such as gastrointestinal damage and the increased risk of cardiovascular disease. The traditional Chinese prescription Simiao Powder (SMP) has a long history in the treatment of acute gouty arthritis (AGA) and has a good curative effect. However, the mechanism and target of its therapeutic effects are still not completely understood. METHODS: Potential active compounds (PACs) and targets of SMP were found in the TCMSP database, and the disease target genes related to AGA were obtained by searching CTD, DisGeNET, DrugBank, GeneCards, TTD, OMIM, and PharmGKB disease databases with “acute gouty arthritis” and “Arthritis, Gouty” as keywords, respectively. The network of “Traditional Chinese medicine (TCM)-PACs-potential targets of acute gouty arthritis” was constructed with the Cytoscape 3.7.2 software, and the target genes of acute gouty arthritis were intersected with genes regulated by active compounds of SMP. The resultant common gene targets were input into Cytoscape 3.7.2 software, and the BisoGenet plug-in was used to construct a PPI network. The GO functional enrichment analysis and KEGG pathway enrichment analysis of the intersecting target proteins were performed using R software and corresponding program packages. The molecular docking verification was carried out between the potentially active compounds of SMP and the core target at the same time. RESULTS: 40 active components and 203 targets were identified, of which 95 targets were common targets for the drugs and diseases. GO function enrichment analysis revealed that SMP regulated several biological processes, such as response to lipopolysaccharide and oxidative stress, RNA polymerase II transcription regulator complex, protein kinase complex, and other cellular and molecular processes, including DNA-binding transcription factor binding. Results of KEGG pathway analysis showed that SMP was associated with AGA-related pathways such as interleukin-17 (IL-17), tumor necrosis factor (TNF), p53, and hypoxia-inducible factor 1 (HIF-1) signaling pathways. The results of molecular docking showed that active compounds in SMP exhibited strong binding to five core protein receptors (TP53, FN1, ESR1, CDK2, and HSPA5). CONCLUSIONS: Active components of SMP, such as quercetin, kaempferol, wogonin, baicalein, beta-sitosterol, and rutaecarpine, showed therapeutic effects on AGA. These compounds were strongly associated with core target proteins (such as TP53, FN1, ESR1, CDK2, and HSPA5). This study reveals that IL-17, TNF, p53, and HIF-1 signaling pathways mediate the therapeutic effects of SMP on AGA. These findings expand our understanding of the mechanism of SMP in the treatment of AGA. Gouty arthritis (GA) is characterized by acute onset of single joint redness, swelling, heat, and pain at night or in the morning. e pain progressively worsens, and in severe cases, patients often suffer from cutting pain, which often reaches a peak within 24 hours [1] . e number of gout patients has increased drastically due to dietary changes and high intake of high-purine foods and beer [2] . According to the gout epidemic survey in Hong Kong, the prevalence of gout increased from 1.56% in 2006 to −2.92% in 2016 [3] . In the United States, the prevalence of gout was about 3.9% in 2016, with an estimated 9.2 million gout patients [4] . Acute gouty arthritis (AGA) is the first symptom of gout. Severe pain can reduce the quality of life of patients. Recurrent acute arthritis can destroy joints and damage internal organs [5] . Gout treatment guidelines issued in 2012 by the American College of Rheumatology (ACR) recommend nonsteroidal anti-inflammatory drugs (NSAIDs) or oral colchicine for acute attacks of gout [6] . It has been reported that NSAIDs are harmful to the gastrointestinal tract, liver, and kidney, central nervous system, etc. [7] . Colchicine is an anti-inflammatory drug commonly used in the treatment of acute gout. However, when taken in large doses, it easily causes gastrointestinal tract discomfort, liver and kidney damage, or heart disease. Meanwhile, it may lead to poisoning in elderly patients [8] . erefore, safer and more effective drugs for the treatment of AGA are urgently needed. Simiao Powder (SMP) is a well-known prescription used in ancient China for the treatment of joint pain [9] . is prescription originated from Chengfang Biandu in the Qing Dynasty (1904 A.D.) . SMP is composed of Rhizoma Atractylodis (Cang Zhu), Cortex Phellodendri (Huang Bo) , Radix Vladimiriae (Niu Xi), and Semen Coicis (Yi Yi Ren), and it could clear heat, dry dampness, and promote blood circulation to invigorate the tendons. In the gouty arthritis model, Lin et al. revealed that SMP treatment could effectively relieve joint symptoms and improve laboratory indexes (e.g., serum uric acid content or inflammatory cytokines IL-1b, IL-9, IFNg, and so on). Moreover, the anti-inflammatory effect of SMP was stronger than febuxostat [10] . A systematic review and meta-analysis demonstrated that SMP possesses anti-inflammatory, analgesic, and uric acid-lowering effects and hence can treat AGA. Jiawei reported that SMP is superior to other anti-inflammatory drugs or combined uric acid-lowering drugs. Compared to modern medications, SMP is associated with fewer adverse events [11] . However, the mechanism and the therapeutic target of SMP in the management of AGA are vague and are the main limiting factors for its widespread clinical application [11] . e entire human body is a complex network, and the occurrence and progression of a disease are the results of the comprehensive action of multiple factors. Single-targeted therapy cannot meet the needs of multitarget and multipathway treatment of diseases. e network pharmacology concept put forward by Hopkins in 2007 [12] provides a "multiway" and "multitarget" approach to drug analysis. It is similar to the thoughts of TCM compound prescription, as well as the characteristics of the overall TCM compatibility and comprehensive and multipathway treatment of diseases. e present study employed network pharmacology and molecular docking techniques to establish the active components of SMP in AGA treatment and predicted the potential target and drug action pathways of SMP. Collectively, we aimed to explore the potential mechanism of action of SMP and provide a reference for pharmacological research and clinical application of this prescription. e specific flow chart is shown in Figure 1 . Rhizoma Atractylodis (Cang Zhu), Cortex Phellodendri (Huang Bo) , Radix Vladimiriae (Niu Xi), and Semen Coicis (Yi Yi Ren), SMP components, were acquired from the traditional Chinese medicine systems pharmacology database and analysis platform (TCMSP, http://tcmspw.com/ tcmsp.php), capturing all the potential active components of drugs in SMP. We screened the active compounds in SMP following the standards of oral bioavailability (OB) ≥30% and drug-likeness (DL) ≥0. 18 . en, a search was undertaken for corresponding targets of active compounds on the TCMSP platform. e identified drug targets were input into the UniProt database (https://www.uniprot.org/). To obtain the abbreviation of the human gene for each target, we set the protein type as "Homo sapiens." e search for target genes related to AGA was achieved using the terms "acute gouty arthritis" and "Arthritis, Gouty" in the Human Gene Database (GeneCards, https://www.genecards.org/), Online Mendelian Inheritance in Man (OMIM, https:// www.omim.org/), the Pharmacogenomics Knowledge Base database (PharmGKB, https://www.pharmgkb.org/), Drug-Bank database (https://www.drugbank.ca/), DisGeNET database (https://www.disgenet.org/), the erapeutic Target Database (TTD, http://db.idrblab.net/ttd/), and Comparative Toxicogenomics Database (CTD, http://ctdbase.org/). e results of the above databases were integrated to obtain the target genes of AGA after deleting the repeated genes. We intersected the targets regulated by active compounds in SMP with the disease target genes of AGA. After that, common targets were obtained. e R 4.0.2 software and its Venn diagram package were employed to generate a Venn diagram of the SMP-AGA-related target. e potential targets and active compounds corresponding to the potential targets of SMP in AGA treatment were introduced into Cytoscape 3.7.2 software. en, we constructed the network of "TCM-active compound-potential targets" and conducted the visualization display. e intersection target was imported into Cytoscape 3.7.2 software. e PPI network was constructed via its plug-in BisoGenet with the following data sources: DIP, BIOGRID, HPRD, BIND, MINT, and INTACT. e plug-in CytoNCA was employed for topology analysis. en, the degree centrality (DC) betweenness centrality (BC) of each node was calculated. A larger DC and BC of the node at the protein location implied that the protein was more important in the constructed PPI network [13] . Because we screened out various important target proteins, other protein interaction parameters, such as closeness centrality (CC) and eigenvector centrality (EC), were further applied to screen core target proteins. e ID of the intersection target was obtained using R4.2.0 software and its "org.Hs.eg.db" package. en, the "clusterProfiler" and other program packages were adopted for GO functional enrichment analysis of the target. A histogram was constructed after screening out the first 10 functional categories of biological process (BP), cellular component (CC), and molecular function (MF). e target proteins were subjected to the KEGG enrichment analysis, whereby the first 30 KEGG pathways were selected to construct the histogram. Information of the first 20 KEGG pathways was introduced into Cytoscape 3.7.2 to draw the KEGG pathway-gene network map. After that, we selected a signal pathway closely related to GA for visual display. Docking. e 2D structure of the potential compound was retrieved from PubChem (https://pubchem.ncbi.nlm.nih. gov/). For small molecules, their energy was minimized using ChemBio3D 2014 software. e 2D structure was converted into a 3D structure. We downloaded the 3D structure of the core target protein from the Protein Data Bank (PDB) database (http://www.rcsb.org). Using the Pymol software, the target protein receptor molecules were processed, including dehydration and removal of ligand small molecules. e target protein receptor molecule was hydrogenated using Autodock Tools 4.2.6 software. e center coordinate and size of the box were set based on the position of the active site of the protein molecule and the area where it potentially acted on the ligand small molecule. Molecular docking was achieved using AutoDock Vina, whereby lower binding energy depicted a better affinity between the receptor and the ligand. e binding energy ≤0 kcal/mol indicated that the compound could bind and interact with the target, whereas the binding energy <−5 kcal/mol demonstrated a very strong binding force. e docking results with the best binding force between each core target protein and active compound were simultaneously presented in 2D images and 3D structures. and their abbreviations were obtained. Information of active compounds and the number of action targets of TCM in SMP are outlined in Table 1 . rough a search in GeneCards, OMIM, PharmGKB, DrugBank, DisGeNET, TTD, and CTD databases, 1,204 target genes associated with AGA were obtained ( Figure 2 ). Corresponding Active Compounds of SMP in the Treatment of AGA. e drug-disease intersection target (the potential target of SMP in AGA treatment) was obtained by intersecting the 203 drug targets with 1204 disease targets using R software, with 95 potential targets ( Figure 3) . Notably, 33 active compounds corresponded to the 95 potential targets. ey were the active compounds of SMP in AGA treatment. Target of AGA Network. We drew and analyzed the potential targets of SMP in the treatment of AGA using Cytoscape 3.7.2 network drawing software. en, a PAC-potential target network diagram of SMP for AGA treatment was constructed ( Figure 4 ). e network diagram comprised 133 nodes (including 95 target genes, 33 drug active components, 4 TCM, and 1 disease name) and 250 edges. We further calculated the degree of the compound in the figure. Notably, a higher degree implied that the compound played a more critical role in the network. e top six active compounds included MOL000098-quercetin, MOL000422kaempferol, MOL000173-wogonin, MOL002714-baicalein, MOL000358beta-sitosterol, and MOL002662-rutaecarpine, with 79, 30, 21, 18, 12, and 7 as the corresponding target numbers, respectively. Determination of Core Targets. After obtaining the potential target genes, they were imported into Cytoscape 3.7.2 software. We then drew the PPI network diagram using the Bisogent plug-in and obtained 5,264 nodes and 133,011 connections ( Figure 5(a) ). For the first topology analysis, DC ≥ 74 and 982 nodes and 43,726 connections were obtained ( Figure 5(b) ). e second topology analysis was conducted with BC ≥ 925.611 (average), CC ≥ 0.581 (average), and EC ≥ 0.096 (average) to identify the crucial target genes; eventually, 54 nodes and 829 lines were obtained. Target proteins with the top five degree values were selected as the core target proteins in the protein network ( Figure 5 (c)), where TP53 protein, FN1 protein, ESR1 protein, CDK2 protein, and HSPA5 protein corresponded to 946 edges, 781 edges, 1,762 edges, 687 edges, and 445 edges, respectively. For GO analysis, BP, CC, and MF were included, and 1,938 items were obtained via BP enrichment analysis (including response to lipopolysaccharide, oxidative stress, reactive oxygen species (ROS), etc.); 36 items via CC enrichment analysis (including RNA polymerase II transcription regulator complex, protein kinase complex, and membrane raft); 145 items via MF enrichment analysis (including DNA-binding transcription factor binding, heme binding, and RNA polymerase II-specific DNA-binding transcription factor binding). To draw the GO function histogram of SMP in AGA treatment, we selected the top 10 BP, CC, and MF results at P < 0.05 ( Figure 6 ). To further elucidate the pathways regulated by the therapeutic target genes, we did a KEGG pathway analysis. Results revealed that these target genes were distributed in 155 pathways. To construct a histogram, the pathways with the top 30 enriched genes were selected (Figure 7 ). GArelated pathways were mainly associated with IL-17, TNF, p53, and HIF-1 signaling pathways. We also analyzed the association of the top 20 pathways with their corresponding target genes by constructing a KEGG pathway-gene network diagram ( Figure 8 ). ere were 83 nodes (including 20 pathways and 63 target genes) and 403 lines. Based on the number of regulatory pathways, the top five genes were RELA, TP53, MAPK1, IKBKB, and CHUK with 16, 15, 15, 15 , and 15 regulatory pathways, respectively. A strong relationship existed between GA and inflammation (the IL-17 pathway is closely related to inflammation). erefore, we constructed a diagram to demonstrate the association of the regulatory target of SMP with the IL-17 pathway (Figure 9 ). Using the AutoDock Vina software, PACs in the network map of "TCM-PAC-potential targets of AGA" were docked with five core target proteins (TP53, FN1, ESR1, CDK2, and HSPA5) in PPI. A higher binding activity between the compound and the target protein receptor implied lower binding energy. Results demonstrated that the docking of 33 active compounds with the 5 core target protein receptors was less than 0 kcal/mol (a majority was less than −5 kcal/mol) ( Table 2 ). e molecular docking results of the compounds with the highest binding energy corresponding to the five targets are displayed in 2D images and 3D structures ( Figure 10 ). e repeated attacks and protracted course of acute gouty arthritis can lead to joint swelling, deformity, and destruction of bone and joint cartilage. Tophi can be formed in many parts of the body, and it could seriously invade joints, kidneys, and even aorta and heart valves in severe cases [14] [15] [16] . For the treatment of gout, anti-inflammatory analgesics are mainly used in the acute stage. After the pain of patients is completely relieved, the use of uric acid-lowering drugs to correct the serum uric acid level is adopted [7, 17, 18] . Studies have found that although febuxostat and allopurinol can effectively reduce blood uric acid levels, they can also increase the risk of cardiovascular disease [19] . Traditional Chinese medicine compounds could function in anti-inflammatory analgesics and lowering uric acid at the same time, which has certain advantages compared with anti-inflammatory analgesics alone [20] [21] [22] . Besides, its relatively fewer adverse reactions and lower price have attracted more and more scholars' attention. According to Figure 4 , the key active components of SMP in the treatment of GA were quercetin, kaempferol, wogonin, baicalein, beta-sitosterol, and rutaecarpine. Quercetin is the active compound of Cortex Phellodendri (Huang Bo) and Radix Vladimiriae (Niu Xi), kaempferol is the active compound of Radix Vladimiriae (Niu Xi), wogonin is the active compound of Rhizoma Atractylodis (Cang Zhu) and Radix Vladimiriae (Niu Xi), baicalein is the active compound of Radix Vladimiriae (Niu Xi), beta-sitosterol is the active compound of Cortex Phellodendri (Huang Bo) and Radix Vladimiriae (Niu Xi), and rutaecarpine is the active compound of Cortex Phellodendri (Huang Bo) . Among them, quercetin and wogonin are the common active components of two traditional Chinese medicines, which is similar to the compatibility and synergism of TCM compounds. Considering Semen Coicis (Yi Yi Ren) as an indispensable TCM in this prescription, the active ingredient stigmasterol, characterized by a great degree value in Figure 4 , was established as one of the crucial active compounds. ese PACs in SMP have a certain curative effect on inhibiting inflammation and lowering blood uric acid level [23] . Among them, quercetin, baicalein, wogonin, and rutaecarpine showed strong anti-inflammatory effects [19] [20] [21] . Baicalein could inhibit the activity of NF-κB and some inflammatory factors, such as monocyte chemotactic protein-1 (MCP-1), interleukins, tumor necrosis factor, and cellular adhesion molecules. In addition, it also clears the reactive oxygen species (ROS) to show anti-inflammatory and antioxidant effects [24] . Moreover, wogonin, a flavonoid from medicinal plants, has shown various biological activities. It potentially inhibits the production of inflammatory mediators by macrophages and lymphocytes [25] . Inhibition of NF-κB and mitogen-activated protein kinase (MAPK) pathways in rutaecarpine-derivative R3 inhibits the NLRP3 inflammasome activation, which Figure 4 : A network of the drug-PAC-potential target of AGA. e left circle represents the active ingredients. Different colors distinguish drug sources of each ingredient; blue represents the active ingredient from Cortex Phellodendri (Huang Bo), yellow represents the active ingredient from Rhizoma Atracylodis (Cang Zhu), orange represents the active ingredient from Semen Coicis (Yi Yi Ren), green represents the active ingredient from Radix Vladimiriae (Niu Xi), and purple represents the common ingredient of various drugs. e square node on the right denotes the target. consequently lowers the expression of proinflammatory cytokine IL-1β [26, 27] . e pathogenesis of GA is highly associated with the inflammatory cascade induced by the activation of the inflammatory bodies of NLRP3 [2] . us, the inhibitory effect of rutaecarpine on the inflammatory body activation of NLRP3 may influence GA treatment. Besides, quercetin and kaempferol may significantly elevate the total antioxidant capacity and inhibit the xanthine oxidase (XOD) effect in hyperuricemia rats [28] . In another study, inhibition of XOD activity could reduce the serum uric acid level and the formation of ROS, consequently reducing the deposition of gout urate crystals [29] . Additional studies found that quercetin could reduce serum uric acid levels in hyperuricemia mice and impede renal insufficiency. is was achieved via the regulation of renal organic ion transport protein and uromodulin, and demonstrated fewer side effects than allopurinol [30, 31] . Betasitosterol (SIT), the main compound among various phytosterols, can reduce the expression of chemokines and inflammatory cytokines. It then regulates various biological HIST1H3I SMC1A HIST4H4 HIST1H2BD EEF1AKMT3 RBM45 NUDT21 KPNA4 HIST1H4E RAPGEF2 MARCKS GIGYF2 SUMO3 LUZP1 USP37 SRSF9 LUC7L2 YEATS4 WIZ PPP1R12A HIST1H2BI KAT6A BAG1 SPICE1 C2CD5 H3F3A TCOF1 GNL2 RSL1D1 RPRD1B DYRK1A NCAPG HIST3H3 SCO2 RBM7 TBC1D4 MYOD1 ZNF24 TRRAP TAF7 WDR82 SYMPK USP39 KPNA6 KMT2C H3F3AP4 HIST1H1A TRIM25 BCOR SLC9A1 ALYREF RBL2 HIST2H3D LLGL2 PRMT8 SMARCAD1 TADA3 GTF2B H3F3B SRRM2 MCM3 RAD21 PUF60 EIF2AK2 HIST1H3A HIST1H3E ID2 HIST1H4F RPL13 DDX21 MAGED1 COPS6 CAMKK2 CSNK2A3 RPA2 CCT4 TOP2A BCAS2 CUL4B DDX17 HNRNPR EZH2 KIF5A MCM5 RAE1 SRP14 TNFRSF14 HNRNPA0 EIF2S1 GBAS MEPCE TUBA4B CEBPZ BRD7 LMO2 SNIP1 HERC4 PIAS2 EDF1 ING4 ATRX TFAP4 TDG GLI1 UBE2O COPS7A MAP1S FOXO1 MEN1 MAX PELP1 HNRNPAB BTBD10 SBF2 MEF2D ZNF496 PSG1 NEIL3 OGG1 TPP1 TOE1 NAT9 FOXR1 FLYWCH2 EP400 TEX11 LZTR1 CDYL ARPC5 RBM5 KDM4B YTHDF2 SNRPN MSL2 MLLT1 MAGEA11 LRWD1 PCGF2 NR2E3 KAT2A EID1 ANAPC7 FAM193B DMAP1 SRP9 GLYR1 MED21 CEBPB CETN2 SIN3B NKX2-1 CXXC1 ARID4A POLR2I CDCA7L TONSL ARHGEF1 EPC1 DBF4 RTF1 COPS8 BRD3 POLR2H UBASH3A MED10 RPP30 CCNK ZFP91-CNTF THAP12 PRCC TAF6 NSD1 VAMP8 MSL1 NSD2 ORC2 CHD7 SATB1 GTF2F1 POLD1 DHFR PRRC2C ZNF219 PDLIM1 LGALS7B SPIN1 PRPF4B SMARCA1 RBM17 TOPBP1 RNF4 ATXN2 PFKL SUPT20H S100A7 ANGPTL4 MIF4GD CIAPIN1 HIRIP3 HIST1H2AB G3BP2 RBM15 XPC USF1 TRAF3IP2 FMNL1 PPP1R8 WDR33 RNGTT PHLDB2 HIST2H2AB CDK7 POLR2K TAF10 MYLK2 CARD8 LAMP2 C14orf166 LBR RAD50 MDN1 TOB1 HIST2H2AA4 FOXQ1 MRPL53 WDR18 CHAF1B RFX5TOX4 MED6 RNF146 STK38 SNAPC1 PFKFB1 IL2RA NKX2-5 LGALS7 BTBD2 HIST1H2BB KMT2E MOV10 MKNK2 GTF3C2 RBM28 RPF2 ANXA6 PHF20 ARID1A TAF2 PAX5 TAF1C ING3 LYL1 ZNF302 MRPL43 CPSF3 DDX52 METTL13 L3MBTL2 TAF1A TARBP2 CHD1 CSTF1 CAMSAP3 MBD3 TFDP3 RPRD1A ANAPC4 ZSCAN1 RFC1 CCAR1 HIST1H2BL PHLPP1 SGSM2 LDB1 KIF26B CDC7 MAGEA2 ESPL1 KDM4C LIG3 GEMIN2 GTF2H1 DTL CBX1 KCND3 POLR2E PPP2R5C CCNT2 LIN54 KAT6B FNDC11 TFDP2 TSPYL4 BDP1 DUSP6 CACNG4 DLX5 BUD13 SMA4 APITD1-CORT KDM4D YY1AP1 RFPL2 NFIX GTF2A2 ACY1 CCNO STAC3 TRIM6-TRIM34 CCDC106 ZNF420 TSTD2 PATZ1 DUSP7 ELK3 CREBZF HOXC9 HMGN2 TXNRD2 MSX2 BATF3 MECOM MAFF DUSP9 RPA4 TRIP11 SULT1E1 ANKZF1 FBXO4 GTF2H4 TAF5L SERPINB4 IRAK1BP1 KEAP1 EIF2A CDC45 TRIM24 ZNF131 HIST2H2AC MORF4L2 POLR2G DCUN1D5 RYBP FOXM1 PIAS3 SKP2 PPP2R5D ARIH1 NFATC1 MARK3 CDC73 RNF114 PPARD FKBP3 LOC100996724 PKN1 FBXW7 RARA CHFR PPFIA1 DHX36 SETD7 CDC25A GPS1 MRPL28 CDK3 POLA2 NSD3 SHMT1 HRNR CREBBP PPID HIST1H2AA MRGBP PCBP2 SPEN CCNE1 SMARCD2 TFIP11 WDR26 DACT1 NR1H2 DRG1 PIAS4 PPARG NAF1 ATF3 S100B SIRT2 BOLA2 MED14 E2F4 NCOA3 CENPB BAG4 BANP APPBP2 RUNX1 HEY2 RXRA ANAPC2 RXRB NEFM CPSF1 TTI2 FANCC VTA1 EIF4E2 STAT6 HIF1AN GTF3C3 TOPORS NKD2 AKAP8 CSTA RBFOX2 SMARCA2 KAT8 OLA1 CNOT9 AMOTL2 BLM HIVEP1 JUN NR2C2 PGR CBX2 KAT2B CCND3 CCNT1 DDB2 ERCC6 MCM10 YY1 HIST2H3C AKAP8L TBP CREB1 SNAI1 NCOA1 FOXO3 CRIP2 NOL3 SMARCD3 TSPYL2 KMT2A AKAP5 RBM3 PPP2R2A HIST2H3A DCAF1 RNF41 MORF4L1 TLE1 SSX2IP HIST1H2BA KMT2B DEUP1 WDR5 CEBPA CDK8 DNAJC9 PSPC1 NRIP1 ADNP TUBB1 TCEAL4 AGO1 POM121 CDC27 KLC2 RCOR3 RB1 FTH1 COPRS SMAD7 TAF12 POU2F1 ID1 MYL12A ERC1 MEF2A CEP70 E2F1 SPOP KAT7 RUNX2 TAF1 PGAM5 PSMD5 ORC4 EEF2K XRCC5 HIST2H4A HIST1H3H MED23 FLNB CCNB1 FLAD1 HIST1H4H HAUS1 TERT NFATC2 PARP1 TP53 BARD1 TSSC1 H2AFX DNAJA3 UBE2I TRIM28 HNRNPK STK4 PHC2 TP53BP1 RRM1 SMARCA4 HIST1H4B MAD1L1 HIST1H4J CDK9 STXBP1 KDM5B SIN3A KAT5 ATM HIST1H4K EEF2 KRT5 BRMS1 DHX15 DDB1 HDAC1 DAXX SLC25A1 TJP1 CC2D1A GATA2 PPARGC1A NCOA6 EIF4EBP1 AKAP13 CCNG1 PRNP IRF7 KMT5A FZR1 CHD8 PRKD1 FIP1L1 NCF1C MTF2 AXIN2 ZBTB33 JUND RFFL TFDP1 CCND2 TULP3 MRM3 LOC100653061 MLKL TTC3 EPSTI1 E4F1 ITPK1 ACTL6B HSPB6 FIBP TLR2 NFYC GMNN NRBF2 KLF10 IKZF4 RANBP3 GPR37 SERTAD1 RLIM KIDINS220 USP12 BTG2 ERF HBP1 SLK TRO SASH1 PRDM1 PPP2R5E CDX2 CDKN1C METAP2 RAD54L2 EHHADH CPNE7 ZSWIM8 EHMT1 EGR1 BCL6 SENP1 FBXO18 ETV1 RASSF1 NEXN PPIL1 EPAS1 NTRK3 IL6ST IER5 IL16 RAP1GDS1 PPM1D TMEM62 SOCS2 CTBP2 PRKAA2 ANKRD17 MGEA5 WASL MAPKAPK3 CDC25C LANCL2 MYL6B TCL1A PACSIN1 IFNGR1 PAX2 MNDA ZBTB25 MOAP1 IL15RA NSMCE4A MAGEB18 TNNI3 SPTB TH MED24 ENC1 MUL1 C7orf25 CCNB2 DACH1 NAV1 NR1H3 ESRRA WDR83 MAPKAPK2 RAC3 CA2 RNF126 ETF1 MAP3K5 NUP35 NFATC2IP MTA3 PIAS1 MINK1 HMMR SAFB2 CCND1 CD82 KCNIP3 KRT7 MYH3 NOTCH4 ITGB6 ABHD16A COL3A1 ST14 DPYSL5 EDA2R IP6K2 NPPA PTPRR SELE IL13RA2 ROBO1 PTPN7 PRTN3 IL18 XAF1 LURAP1L KLK2 TRAPPC13 ITPKA MYL3 INPP5B STYK1 PPFIA4 ASRGL1 KRBA1 DUSP2 HOXA5 TBC1D2 TRAPPC11 CHD9 SRMS DENND5B ARHGAP9 HIVEP3 IL27RA MINPP1 ALOX15B GUCY1B3 RGS22 ZNF212 ARID5A TRIB1 GREB1 MFAP4 DUSP4 ANKRD2 HOXB2 NLRC5 CNKSR1 CYTH3 PTPRCAP CER1 REG3A NBEAL2 EYA1 TRIM40 NLRP10 ITPKC DUSP22 IQCG ZNF467 USP31 ANKRD6 ACSBG1 MPO AGBL2 AK4 CYTH4 NEB DEC1 SERPINA4 USP28 CLEC3B NEFH SERPINA1 SDC2 CCDC180 STAT4 TNFRSF10A ELP2 MYOC PDGFA MEF2C METTL3 IRF2 SMAD6 ELK1 PRKAR2A IFNAR1 SOX4 PPP3CC THRSP PDK3 LEF1 TICAM1 TLR4 ANKRD13D PPP4R3A MXI1 RGS7 ZBTB9 LIPH STAT2 SUV39H2 PDGFB PSMC3IP IL2RG IL12RB1 ZNF133 VWF GALNT12 INCA1 SDC4 JMJD1C RNH1 RRM2B ITGB5 TRIB3 CHAF1A ARHGEF5 AKT2CDKN2C LDOC1 POLL PRMT2 MAPK14 RRM2 NOTCH1 RIPK2 MNAT1 IKZF3 MED12 NR1H4 NR4A1 ATXN7 CASP9 PSMC5 MAPK8 SMAD4 BIRC2 DYNLT1 SMAD9 CDKN1B CPSF7 CDC25B FOS AP3M1 ATN1 PPP4C STAT3 SNCA MBP GRIP1 PRKAR1A NEK2 BRAP STRAP ZBTB17 UBE2E2 STK24 ELOC GSK3A PCBD1 STAT5A BRCC3 PPM1A MYEF2 AXIN1 ARPC2 CDK11B HIST1H1B TRIM39 RB1CC1 DVL1 FADD TRIM54 TNFAIP3 USP4 TCERG1 ZBTB8A EPN1 PTPRS FHL2 HIPK3 DST LOC400927-CSNK1E RGS3 ITK PTPN12 MAP2K3 FGR RABGEF1 PLG HCLS1 HLA-DRB5 IL1A CCL2 CRTC2 MRPS34 SOS2 GABARAPL1 APPL1 FEN1 DPYSL2 EIF4A2 HES1 NFKBIE KRTAP10-7 OPA1 TIAM1 DDX6 DDX58 ETS1 PPP2R5A FBXL12 CORO7 LCK TGFB1 LIMK1 PIK3CA ARFGAP3 MYO5A HIPK2 KSR1 GZMB PTGS2 CDKN2A TRAF2 S100A8 WWOX USP2 RBX1 DSP DAPK1 STAT1 GSK3B SF3B2 HIF1A UBE2S UBASH3B RAB11B MAPK3 TMEM63B KHDRBS1 YWHAB FOXK1 CDC42 ANXA2 TGM2 SH3KBP1 UCHL5 RET DNAJC7 MAPK1 RNF43 BRD4 EIF3D GLUL MAPK9 SLC2A1 TMOD1 RFC4 STAT5B PSMA4 DNM1L JAK1 PAK1 NEDD4 MAP3K7 IRS4 AP1B1 OTUD4 GRB7 TFCP2 NAA10 SMURF2 CDH1 WAS ELOB TFAP2C TMX2-CTNND1 CCL5 PTPRO CHST10 SH2D1A TNFRSF25 NPDC1 IDSTHBS1 AAK1 FRAT1 ARID3A COMT CRADD HBEGF ATP2B2 TMEM185A SNTB2 DOK1 PRKCQ EXOC7 RGS20 FBP2 TLDC1 GRB10 ZNF510 ADAM15 CPNE6 FES CARD11 ALPP VRK2 BAD PTPN6 PECAM1 SH2D2A CREM ARNT2 CARHSP1 CISH SPTLC1 CTSG CDC34 TFAP2A DHFRP1 NEK9 TRMT2A RPS6KA2 TSC2 ARIH2 C11orf84 WAC ARAP1 KDM2A KRAS MAPK12 MAP2K2 RNF14 ASB15 IRS2 PTPA MAP2K6 MAP2K4 NUMB RCHY1 BAIAP2 ARPC3 SPAG9 LAMTOR5 PARK7 SOCS3 PALLD ASXL1 KCTD13 PDGFRA PRKCD SORBS3 MLH1 FHL1 RAP1B GABARAP PFKP VAV1 DYRK1B PLAUR PRKCZ FBXO11 HDAC8 ACTN2 ADRM1 TNNT1 MEOX2 CASP7 MAPK7 RPS6KA4 PFN1 NR2C1 PLCG1 ITCH CREB3 CSNK1E MAP2K7 MAP2K1 CTNND1 SEC61B ERRFI1 CAST OXSR1 CASP6 BUB1 MALT1 NCKAP1 WWP1 JAK2 IL2RB PTPRJ PGD CLTCL1 RAB14 TMED9 SEC24C PPP3CA ATP2B1 MAVS ALDH3B1 MAPK11 TNIP1 PKMYT1 FBP1 SIAH2 AK2 CD19 PFDN2 CASK TPX2 LMO4 SNAP29 KRT10 NME5 ATRNL1 ACKR1 SPOCK3 MMP10 MMP8 TMPRSS6 CCR2 PZP TNFRSF11B MMP1 BCAN ADRB3 ACAN GNA14 CMA1 CCR1 ITGAD CXCL2 LTBP1 COMMD10 ADCY5 COL4A6 PCOLCE KSR2 ARRDC3 COL7A1 MMP9 GABRR2 PSENEN IFNAR2 PROC MAP3K21 KLK3EDNRB PTGS1 TFPI NEK11 PPP2R5B C1QB IL1B SEMG1 KRT86 ITGA3 C9orf3 APBA2 CAPN7 ELANE PTPRE RGS11 DOK5 NKIRAS1 CNKSR2 C4A DZIP1 CTSV BAAT GRIN2A RCAN1 C6 ANK1 DNAJB12 LAMA1 SOS1 CPB2 ACKR2 RNASE1 MMP17 FSTL3 CCR3 COMP HAPLN1 THBD FGG BNIP3L UCK2 GLCE HOXC10 SH2B2 MCAM PRKCH NCAPG2 SRGN PAK6 ROBO2 RASL10B CEBPG STK40 RHOBTB3 LRRC1 PPIL2 PTK6 RASGRF1 IL24 FBXO21 RRAS2 PHF1 WT1 KLK9 HEMGN ERAL1 OTUD7B GAS2L1 MICALL2 TMEM54 CDC14B ATPIF1 USP24 DFNA5 FGFR4 WSB1 GNG11 EGLN3 ZBTB24 C3 FAM175B SCAMP1 PLK3 CAMK4 PPARGC1B BMPR1A AREG GJA1 ERCC3 SHARPIN PATJ CSF3R FER UBXN11 MLH3 ETV3 ADH5 ZNHIT1 MAP3K2 GFI1 STK39 DUSP3 DEDD RNF34 RNF38 NOXA1 AGER SYCE1 LACRT APBA3 ARG1 GRM7 ATF1 OTUD5 PPP3R2 COL4A5 REV1 ANKHD1 STAP2 DGKZ GNB4 ZFYVE9 PRKCSH CXCR4 TNK2 ANXA5 BID ARRDC1 CSK CAMK2D FGFR3 USP33 PRKCE MAP2K5 BTK ENAH EPS8 RBCK1 EIF1AX PRKCB PTK2 OS9 MAP4K1 ERBB2 TEPSIN P3H1 MLST8 GNB5 CABLES1 FASLG CASP10 MUC1 INPPL1 SORBS2 BIRC7 TNPO1 BIRC3 ITGB1 KRT16 LOC653513 TSN ATG12 TOM1L1 KRTAP10-3 UXT TPT1 PIK3R1 BCAP31 STAM2 PTK2B GSN DAB2 GNB2 TPM1 LOC100996717 PPP2R1B KRTAP10- functions, including anti-inflammatory, analgesic, immunomodulatory, and antimicrobial functions [32, 33] . Also, stigmasterol can inhibit the inflammation induced by sodium urate crystals and XOD activity in mice, a phenomenon that validates its antigout effect [34] . Herein, to obtain the core target proteins of SMP in the treatment of GA disease, the PPI network of intersecting target proteins was constructed. Also, we performed two topological screens on the SMP target for GA treatment based on DC, BC, CC, and EC. TP53, FN1, ESR1, CDK2, and HSPA5 were the five core target proteins. Based on the existing reports, TP53, also known as p53, contributes to transcriptional regulation of the cell cycle, DNA repair, cell survival, and cell metabolism [35] . Inhibition of p53 exerts a substantial effect on promoting the senescence of IL-1β-induced chondrocytes [36] . e potential role of TP53 in the regulation of inflammation has been described, whereby it significantly inhibits the production of proinflammatory factor IL-6 [37] . e overexpression of FN1 can activate TGF-Akt/PI3K/Akt signal pathway to promote cell viability and differentiation capacity [38] . Cyclin-dependent kinase (CDK) is the main regulator of cell division. It can be potentially triggered by different cyclins at different cell cycle stages [39] , and it can regulate the secretion of inflammatory cytokines in macrophages [40] and inhibit CDK2. In consequence, a reduction in chemotaxis of primary neutrophils outlines the role of CDK2 in regulating inflammation [39] . Estrogen receptor 1 (ESR1) is a subtype of human ESR, expressed in chondrocytes, stromal cells, and osteoblasts [41] . In particular, ESR can induce the transcription of related target genes to promote the proliferation and differentiation of tissue cells as they bind to estrogen [42] . Heat shock protein family A member 5 (HSPA5) gene can also participate in the inflammatory process of various types of osteoarthritis as it encodes the binding immunoglobulin protein (BiP) of the endoplasmic reticulum Hsp70 family [43] . Following the KEGG signal pathway analysis, the mechanisms of SMP in the treatment of AGA were mainly anti-inflammation and protection of the cartilage. e critical inflammatory signaling pathways included TNF and IL-17, whereas the apoptosis signaling pathways included p53 and HIF. Current pieces of research on the mechanism of gout have reported that the phagocytosis of MSU crystal triggers the change of inflammatory cell state of synovial cells in GA pathogenesis [14] . For instance, the deposition of MSU crystals promotes the local release of TNF-α and IL-1β, which causes persistent gout episodes [44] . IL-17 also stimulates macrophages and monocytes to produce Figure 9 : e IL-17 signaling pathway. e green nodes in the road map denote the genes existing in our SMP network. Evidence-Based Complementary and Alternative Medicine proinflammatory factors, including IL-1β, TNF-α, and IFNc ( Figure 9 ). As a powerful proinflammatory cytokine, IL-17 can increase serum IL-17 levels 8 hours following the acute attack of gout [45] . Moreover, in several arthritic animal models, the inhibition of IL-17 expression was found to limit inflammation and reduce joint erosion [46] . e TNF signaling pathway has also proved to be a crucial inflammatory signal pathway. Signal transduction is mediated by TNF receptor 1 (TNFR1) and receptor-2 (TNFR2). TNFR2 is, in most cases, expressed in immune cells. It binds to TNF-α and TNF-β to regulate immune response [47] . TNF-α is a proinflammatory cytokine produced by different cell types, such as macrophages, lymphocytes, and fibroblasts, and reflects inflammation, infection, and other environmental stresses [48] . Previous reports showed that inhibition of TNF-α expression in synovial cells during AGA could effectively inhibit local inflammation [49, 50] . e physiological dose of soluble uric acid exerts a specific protective effect on cartilage [51] . However, following repeated attacks by GA, the articular cartilage edge is damaged, the articular surface becomes irregular, the joint space becomes narrow, and MSU deposition occurs [52] . A study found that reduced articular cartilage matrix secretion in patients with GA was associated with chondrocyte apoptosis [53] . p53 can regulate cell differentiation and senescence. e inhibition of p53 expression potentially improves senescence and affects the destruction of IL-1β-induced chondrocytes [36] . Compared to the inflammatory signaling pathway, the HIF-1 signaling pathway is slightly less in gout studies. As a transcription factor, activation of HIF-1α expression in synovial cells may be induced during hypoxia. Synovial hyperplasia follows the repeated infiltration of inflammatory cells in the joint. On the other hand, hypoxia is associated with immune cell infiltration and synovial hyperplasia. erefore, the upregulation of synovium-derived HIF-1α occurs in the pathogenesis of rheumatoid arthritis (RA) and osteoarthritis (OA), which are hypoxia-associated diseases [54, 55] . HIF-1α exerts a regulatory role in the function of immune cells. Activated LPS-induced macrophages can also express HIF-1α, which is crucial in glycolysis and the induction of proinflammation [56] . e therapeutic effect of SMP on AGA may be derived through the regulation of the inflammatory signal pathway, p53 apoptosis signal, and HIF-1signaling pathway. And other top-ranked signaling pathways, such as the AGE-RAGE signaling pathway in diabetic complications, fluid shear stress, and atherosclerosis, etc., still lack their gout-related studies, which are Evidence-Based Complementary and Alternative Medicine likely to be the future direction of gout mechanism research. According to the space matching and energy matching relationship between molecules, the core target protein of SMP in AGA treatment was docked with active compounds. is provides a reference for the subsequent research and development of targeted drugs. e 2D image of molecular docking depicts the binding mode between the core target protein and the compound as well as the interaction with the surrounding amino acid residues. Hydrophobic interaction best describes the main association of target protein TP53, FN1, and ESR1 with Inophyllum E. e target protein CDK2 residue Leu83 (A) forms a hydrogen bond with Inophyllum E, whereas the residues Asp34 (A), Lys96 (A), r37 (A), and Gly227 (A) of the target protein HSPA5 form five hydrogen bonds with baicalein. e main forces between ligand and protein are hydrophobic force and hydrogen bond, which both are chemical bonds with strong binding force. According to Table 2, key components of SMP have strong binding activity with core target proteins, such as TP53, FN1, ESR1, CDK2, and HSPA5, suggesting that SMP may play its pharmacological role by regulating these key targets. However, there are still some Evidence-Based Complementary and Alternative Medicine shortcomings in this study, and the conclusions need to be further verified by in vivo, in vitro, and clinical trials. e present study systematically expounds the core compounds and molecular action mechanism of SMP in the treatment of AGA. e core compounds of SMP, including quercetin, kaempferol, wogonin, baicalein, and beta-sitosterol, were screened via network pharmacology, whereas the core targets of AGA including TP53, FN1, ESR1, CDK2, and HSPA5 were screened out via PPI. ese core compounds are characterized by stable binding activity to the core targets. Also, SMP could regulate signal pathways related to AGA disease, for example, TNF, IL-17, p53, and HIF signaling pathways. ese findings suggest the potential synergistic role of SMP in treating AGA via multiple components, multitargets, multiple biological functions, and multiple signal pathways. What makes gouty inflammation so variable? Gout: state of the art after a decade of developments Epidemiology of gout in Hong Kong: a populationbased study from Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the national health and nutrition examination survey Trans-chalcone attenuates pain and inflammation in experimental acute gout arthritis in mice American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective Colchicine: risk of severe toxicity and death from drug overdose Integrating network pharmacology with molecular docking to unravel the active compounds and potential mechanism of simiao pill treating rheumatoid arthritis Simiao decoction alleviates gouty arthritis by modulating proinflammatory cytokines and the gut ecosystem e effects of modified simiao decoction in the treatment of gouty arthritis: a systematic review and meta-analysis Network pharmacology Drug target prediction based on the herbs components: the study on the multitargets pharmacological mechanism of qishenkeli acting on the coronary heart disease Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis erapeutic approaches in the treatment of gout Heart disease and the risk of allopurinol-associated severe cutaneous adverse reactions: a general population-based cohort study Review on the potential action mechanisms of Chinese medicines in treating coronavirus disease 2019 (COVID-19) Developments in drug delivery of bioactive alkaloids derived from traditional Chinese medicine Insights into the action mechanisms of traditional Chinese medicine in osteoarthritis e genus Achyranthes: a review on traditional uses, phytochemistry, and pharmacological activities Anti-inflammatory effects and mechanisms of the ethanol extract of Evodia rutaecarpa and its bioactive components on neutrophils and microglial cells Natural products as a crucial source of anti-inflammatory drugs: recent trends and advancements Chinese herbal medicine si-miao-san decoction for acute gouty arthritis: a protocol for systematic review and meta-analysis of randomized controlled trials erapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders Potential therapeutic and pharmacological effects of Wogonin: an updated review e inhibitor effect of RKIP on inflammasome activation and inflammasome-dependent diseases Rutaecarpine derivative R3 attenuates atherosclerosis via inhibiting NLRP3 inflammasome-related inflammation and modulating cholesterol transport Effects of parsley (Petroselinum crispum) and its flavonol constituents, kaempferol and quercetin, on serum uric acid levels, biomarkers of oxidative stress and liver xanthine oxidoreductase aactivity in Oxonate-induced hyperuricemic rats erapeutic efficacy of urinile against gouty arthritis Quercetin regulates organic ion transporter and uromodulin expression and improves renal function in hyperuricemic mice Effects of Biota orientalis extract and its flavonoid constituents, quercetin and rutin on serum uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver β-sitosterol attenuates the intracranial aneurysm growth by suppressing TNF-α-mediated mechanism An update on β-sitosterol: a potential herbal nutraceutical for diabetic management Lychnophora pinaster ethanolic extract and its chemical constituents ameliorate hyperuricemia and related inflammation What 20 years of research has taught us about the TP53 p.R337H mutation GPR39 agonist TC-G 1008 ameliorates IL-1β-induced chondrocyte senescence p53 predominantly regulates IL-6 production and suppresses synovial inflammation in fibroblast-like synoviocytes and adjuvant-induced arthritis FN1 promotes chondrocyte differentiation and collagen production via TGFβ/PI3K/Akt pathway in mice with femoral fracture Phenotypical microRNA screen reveals a noncanonical role of CDK2 in regulating neutrophil migration Immunomodulatory roles of cell cycle regulators Localization of estrogen receptors alpha and beta. In the articular surface of the rat femur Polymorphisms in the gene encoding estrogen receptor alpha are associated with osteoarthritis in Han Chinese women HSPA5 Gene encoding Hsp70 chaperone BiP in the endoplasmic reticulum Phagocytosis of monosodium urate crystals by human synoviocytes induces inflammation Serum levels of IL-17 are elevated in patients with acute gouty arthritis Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1 TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease Biologics in development for rheumatoid arthritis: relevance to osteoarthritis Efficacy of Xixiancao (Herba Siegesbeckiae Orientalis) on interactions between nuclear factor kappa-B and inflammatory cytokines in inflammatory reactions of rat synovial cells induced by sodium urate e effects of carvacrol on inflammatory cytokines and the apoptosis of cartilage in rats with gouty arthritis Physiological concentrations of soluble uric acid are chondroprotective and anti-inflammatory Metabolism of crystals within the joint Suppressive effect of sanmiao formula on experimental gouty arthritis by inhibiting cartilage matrix degradation: an in vivo and in vitro study Current and novel therapeutic targets in the treatment of rheumatoid arthritis Anti-arthritis effect of berberine associated with regulating energy metabolism of macrophages through AMPK/HIF-1α pathway Chaetocin attenuates gout in mice through inhibiting HIF-1α and NLRP3 inflammasome-dependent IL-1β secretion in macrophages Acknowledgments e authors would like to thank Freescience (http://www. home-for-researchers.com) for the help with the English language.is research was financially supported by the National Natural Science Foundation of China (Nos. Simiao Powder AGA:Acute gouty arthritis TCM:Traditional Chinese medicine IL-17:Interleukin-17 TNF:Tumor necrosis factor HIF-1:Hypoxia-inducible factor 1 GA:Gouty arthritis ACR:American College of Rheumatology NSAIDs:Nonsteroidal anti-inflammatory drugs TCMSP:Traditional Chinese medicine systems pharmacology database and analysis platform OB:Oral bioavailability DL:Drug-likeness OMIM:Online Data Availability e data for this study can be provided by the corresponding author (Wei Liu: fengshiliuwei@163.com). ere are no conflicts of interest between these authors. Yihua Fan, Wei Liu, and Yue Jin have contributed equally to this work and are co-first authors.